The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

On-Demand Educational Webinars
Controlling and Managing the Capital Equipment Process
When purchasing is involved at the start of the capital equipment process, it can lead to better value outcomes and improved customer experience at…
Podcasts
Podcast: What Hospitals Use as a Basis for Decision Making
Brent Petty discusses what forces are currently affecting healthcare and the platform hospitals use for decision making criteria.
Podcasts
Optimizing Technology For Revenue Cycle Success: Vendor Solutions and Training - Part 3
Hear how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration.
Podcasts
Optimizing Technology For Revenue Cycle Success: Components and Terminology 101 - Part 1
Hear how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration.
Podcasts
Optimizing Technology For Revenue Cycle Success: Integrating New Technology and Databases - Part 2
Hear how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration
On-Demand Educational Webinars
Malnutrition Care Management
Advocate Health Care developed a provider-supplier partnership that reduced re-admission rates and improved quality of care inside and outside of the…